Sandoz, Inc. (“Sandoz”) is initiating a voluntary recall of one (1) lot of Cefazolin for Injection, USP, 1 gram per vial.
Dans le traitement de la cholestase intrahépatique familiale chez les personnes atteintes âgées de 3 ans et plus.
Affected device lots may experience tip separation; field complaints reported that the tip separation can occur both prior to and during patient contact.
mRNA COVID-19 Vaccines: FDA Safety Communication - FDA Approves Required Updated Warning in Labeling Regarding Myocarditis and Pericarditis Following Vaccination
The U.S. Food and Drug Administration (FDA) is alerting health care providers about import alerts for certain medical devices manufactured in Japan by Olympus Medical Systems Corporation (Olympus) and its subsidiaries.
80.211.154.110